with the transferee company (Suven Pharmaceuticals) will create concentrated management focus and integration with uniform management procedures and seamless implementation of policy changes.

Merck (NYSE: MRK) and Moderna , Inc. (Nasdaq ... In contrast, TD Cowen has kept a Hold rating on Moderna shares, adjusting the company's financial model, including a reduction in projected ...

CY Yang covers the Healthcare sector, focusing on stocks such as Merck & Company, Amylyx Pharmaceuticals Inc, and Neumora Therapeutics, Inc.. Merck & Company has an analyst consensus of Strong Buy ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired ... New Haven, Connecticut-based Modifi is a pre-clinical stage company, which develops cancer therapies that aim to selectively ...

About Merck & Co Inc and Teva Pharmaceutical Industries Ltd (ADR) Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The ...

Domino Printing Sciences has launched a suite of new enhancements for its K600G variable data printing solution, designed for pharmaceutical manufacturers individual dose serialisation. The K600G ...

Merck has reported a string of setbacks in the development of cancer and multiple sclerosis drugs in recent years. The company however raised the mid-term outlook for its electronics division to a ...

Longboard was founded in 2020 by Arena Pharmaceuticals, another San Diego biopharma company that was later acquired by Pfizer. A year later, Longboard entered the public market through an ...

“I’d like to thank the team at Merck, Livingston for their continued hard work and dedication. Their consistent delivery for the company has resulted in this further investment. It’s a proud ...

Shares of Longboard Pharmaceuticals Inc. are surging more than 51% Monday, boosted by H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical company.

Work as a pharmaceutical researcher and get ready for doctoral study, with a research master’s focused exclusively on a 10-month novel research project in the pharmaceutical sciences specialism of ...